Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Specified Drug Use-results Survey for Long-term Use of Prograf Capsules in Patient With Interstitial Pneumonia Associated With Polymyositis/Dermatomyositis

NCT02159651 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT02159651
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02159651 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Specified Drug Use-results Survey for Long-term Use of Prograf Capsules in Patient With Interstitial Pneumonia Associated With Polymyositis/Dermatomyositis
Lead sponsor
Astellas Pharma Inc
Phase
Observational
Overall status
Completed
Start date
April 1, 2014
Completion date
December 23, 2019
Enrollment
179 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

interstitial pneumonia associated with polymyositis/dermatomyositis